DeepScribe Review
VisitAI medical scribe that writes your clinical notes automatically
DeepScribe is an AI-powered ambient medical scribe that converts patient conversations into clinical documentation.
AI Panel Score
7.7/10
6 AI reviews
Reviewed
AI medical scribe that writes your clinical notes automatically
DeepScribe is an AI-powered ambient medical scribe that converts patient conversations into clinical documentation.
AI Panel Score
6 AI reviews
Reviewed
DeepScribe is an ambient clinical intelligence platform built for healthcare providers. It passively listens to patient-physician encounters and uses AI to transcribe and structure the conversation into complete clinical notes, which are then pushed directly into the provider's electronic health record system. The goal is to eliminate the manual documentation work that contributes to physician burnout.
The product is aimed at individual physicians, medical groups, and health systems across a range of specialties. By automating note generation during or after appointments, DeepScribe reduces the time clinicians spend on after-hours charting, commonly referred to as "pajama time" in the healthcare industry.
Key capabilities include real-time ambient transcription, specialty-specific note templates, EHR integration with systems such as Epic and Athenahealth, and a review interface where providers can edit and approve notes before finalizing them. The AI models are trained on medical terminology and clinical language to improve accuracy over general-purpose transcription tools.
DeepScribe operates in the broader ambient clinical intelligence market, competing with products such as Nuance DAX, Suki, and Nabla. It differentiates through its focus on automation depth and its specialty-specific documentation support.
Pricing is typically structured for enterprise and practice-level contracts, and the company generally requires direct engagement for quotes rather than publishing standard pricing publicly.
Uses advanced speech recognition to listen to and document the natural conversation between clinician and patient as ambient audio, automatically generating clinical notes.
Pulls forward past notes, labs, imaging, medications, and diagnoses to adapt each new clinical note to the full scope of the patient's care journey.
Provides post-visit diagnosis intelligence to inform accurate and complete clinical documentation and coding.
Delivers specialty-specific ambient documentation tailored for oncology, including automated interval history and comprehensive pre-charting for cancer care.
Provides clinicians with pre-visit preparation by surfacing the full context of a patient's care history before they walk into the appointment.
Surfaces key clinical insights at the point of care to help health systems achieve quality and value-based care goals.
Surfaces Hierarchical Condition Category (HCC) coding insights during the pre-visit phase to support risk adjustment and value-based care documentation.
Automates complete and compliant medical coding with real-time insights and audit-ready documentation to ensure proper reimbursement.
Automatically pre-charts patient information before each visit so clinicians arrive prepared with relevant clinical context already populated.
Automates the delivery of orders and key patient data directly into the EHR as part of the post-visit workflow.
Learns the clinician's individual style and voice over time, allowing nearly limitless fine-tuning of clinical note formatting and content.
Integrates with the most widely used electronic health record systems to fit ambient AI documentation into existing clinical workflows.
Quote-based pricing for smaller practices and individual providers. DeepScribe does not publish self-serve pricing; all plans require a sales consultation and demo. Third-party sources estimate costs in the range of $350–$500/provider/month for smaller deployments, with onboarding and setup fees of $1,000–$5,000.
Custom enterprise pricing for large hospitals, multi-specialty groups, and health systems. Requires sales consultation and negotiated Order Form. Third-party sources estimate costs of $500–$750/provider/month at scale, with large organizations (100+ users) potentially reaching ~$20,000/month via negotiated rates.
KLAS 98.8, oncology depth, and a feature set that outpaces Nuance DAX on specialty care.
“DeepScribe is a serious ambient scribe platform with real specialty differentiation and enterprise-grade security. The opaque pricing is annoying, but the KLAS score and oncology focus tell you this isn't vaporware.”
98.8 KLAS performance score. That's not a marketing number — that's a clinical peer review. And 5 million oncology visits annually suggests real production scale, not a pilot masquerading as a product. Nuance DAX has broader name recognition, but DeepScribe's Oncology-Specific AI and SmartPrep pre-visit intelligence are purpose-built depth that generalist scribes won't match.
The feature stack goes beyond transcription. Context-Aware Documentation pulls forward labs, imaging, and prior notes. HCC Code Insights surface risk-adjustment opportunities before the visit ends. That's workflow transformation, not just note-taking automation — which means the strategic case holds up.
The tradeoff: $350–$500 per provider per month for smaller practices, with onboarding fees up to $5,000. That math requires real adoption discipline. No free trial means you're committing on a demo, which is a legitimate procurement risk worth flagging.
Specialty-specific depth in oncology, cardiology, and urology differentiates DeepScribe from broader competitors like Nuance DAX and Suki.
A 98.8 KLAS score and SOC 2 Type II certification make this an easy board defense — clinical peer validation is exactly what a skeptical CFO wants to see.
Ambient documentation ROI is well-documented in the category, but no free trial and up to $5,000 in onboarding fees mean time-to-value depends heavily on implementation discipline.
SmartPrep, HCC Code Insights, and AI Coding move this well past documentation savings into revenue cycle and quality-based care outcomes.
KLAS recognition and 5M oncology visits annually signal a durable business, but no public funding data makes a 36-month runway assessment a genuine unknown.
Specialty practices or health systems where documentation depth and coding accuracy directly affect reimbursement.
You need transparent self-serve pricing and a trial before committing budget.
KLAS-rated ambient scribe with specialty depth that Nuance DAX can't match at the visit level.
“DeepScribe has moved well past transcription — HCC coding, SmartPrep pre-visit intelligence, and oncology-specific AI make this a clinical workflow platform, not just a documentation shortcut. The 99.5 KLAS rating and 5 million oncology visits annually suggest real clinical validation, not demo-ware.”
The feature architecture here is serious. Context-Aware Documentation pulling forward labs, imaging, and medications into the live note isn't a nice-to-have — it's the difference between a scribe and a clinical intelligence layer. Diagnosis Intelligence and HCC Code Insights sitting inside the same workflow means this touches reimbursement accuracy, which is where CFOs and CMOs converge. Someone who understands value-based care contracts built this product stack.
The specialty depth is the real differentiator. Oncology-specific AI with automated interval history addresses one of the highest-documentation-burden specialties in the building. If we're deploying across a multi-specialty group, $350–$500 per provider per month is defensible against the cost of physician burnout and downstream coding errors. The tradeoff: no published EHR connector list and opaque pricing means procurement cycles will drag.
Against Nuance DAX, DeepScribe's pre-visit intelligence layer is a structural advantage. DAX documents the encounter; DeepScribe is trying to own the full periencounter workflow. If that product vision holds, in three years this becomes embedded clinical infrastructure — and those contracts don't unwind easily.
99.5 KLAS rating and 5M oncology visits annually puts DeepScribe ahead of Suki and Nabla on validated clinical volume, competitive with Nuance DAX on specialty differentiation.
Specialty-tuned templates across oncology, cardiology, and urology plus SmartPrep pre-visit prep maps directly to how attending physicians actually structure their day.
Epic and Athenahealth integrations are confirmed, but the docs don't publish a full connector list, which is a procurement risk for health systems with niche or legacy EHRs.
Deep EHR write-back and Customization Studio training on individual clinician voice creates meaningful switching costs — useful lock-in if the vendor is stable, a liability if they aren't.
HCC coding, AI pre-charting, and longitudinal patient context in one platform signals clinical intelligence architecture, not feature accumulation.
Multi-specialty medical groups and health systems prioritizing specialty documentation depth and value-based care coding accuracy.
Solo or small primary care practices needing fast self-serve onboarding without a dedicated IT or implementation resource.
$350–$500/provider/month, zero published pricing, full procurement hostage model.
“DeepScribe's ambient AI is feature-complete and KLAS-rated 98.8. But no self-serve pricing, no trial, and opaque contract terms make TCO nearly impossible to model without a sales call.”
Third-party estimates put small practice cost at $350–$500/provider/month. Add $1,000–$5,000 onboarding. 10-provider practice: ~$60K year 1 including setup. Year 3, assume 15% annual price escalation on renewal — lands closer to $85K cumulative. Enterprise tier estimates hit $500–$750/provider/month, with 100+ provider systems at ~$20K/month. That's $240K/year before integration labor.
Feature set is genuinely broad. SmartPrep, HCC Code Insights, AI Coding, Customization Studio, EHR write-back to Epic and Athenahealth. Oncology-specific AI covering 5 million visits annually is a real differentiator versus Nuance DAX, which skews toward general acute care. KLAS 98.8 score is hard evidence, not marketing copy.
The finance problem: no pricing page, no trial, no published auto-renewal window. Contract terms require negotiated Order Forms. You won't know overage rates until invoice. Suki publishes more upfront. That opacity costs real procurement time and creates renewal leverage risk.
No self-serve, no trial, mandatory demo, custom Order Form — procurement friction is high relative to Suki or Nabla.
Negotiated Order Form model with no published cancellation or auto-renewal terms — standard enterprise hostage structure.
No published pricing page; all tiers require sales consultation per their site.
KLAS score of 98.8 and 5 million oncology visits annually provide measurable third-party validation; coding automation ties directly to reimbursement.
Third-party estimates exist but onboarding fees of $1,000–$5,000 and unknown escalation rates make 3-year modeling speculative.
Mid-size specialty groups in oncology, cardiology, or urology who can absorb procurement friction for a KLAS-validated ambient scribe.
Your practice needs transparent pricing, a trial period, or self-serve procurement before budget approval.
Specialty-first ambient scribe with real coding depth — if you can stomach opaque pricing
“DeepScribe goes deeper than most ambient scribes: specialty-specific templates, HCC coding insights, SmartPrep pre-visit context, and a 98.8 KLAS score aren't marketing. The pricing opacity and no public free trial are real barriers for smaller practices evaluating it against Nuance DAX.”
The 99.5 KLAS rating and 5 million oncology visits per year tell you this isn't vaporware. Context-Aware Documentation pulling forward prior labs, imaging, and meds into each note is the feature that separates ambient scribes from ambient transcription. That's where the daily workflow lives — not in the initial note capture, but in whether the AI understands this is visit 14 of a chemo cycle, not a new patient encounter.
Day-three reality: the Customization Studio learns clinician voice over time, which means the first week is correction-heavy. That's a known tradeoff with any ambient scribe, but DeepScribe's specialty templates should compress that curve faster than a general-purpose tool. Automated Ordering to EHR and AI Coding suggest the post-visit workflow is genuinely considered, not duct-taped on.
At estimated $350–$500/provider/month for small practices, you're paying for depth. Solo practitioners evaluating cost-per-hour saved need the trial they won't get here. Enterprise buyers negotiating at $500–$750/provider/month get dedicated onboarding — that matters when your staff is mid-clinic and the AI misses a field.
Customization Studio and specialty templates suggest the tool improves with use, but correction-heavy early days are a documented ambient scribe category norm.
Oncology-specific interval history and HCC Code Insights are documented with clinical specificity that reads like someone who has seen an oncology workflow, not just described one.
No public changelog and contact-only pricing means every procurement question adds friction; the mobile iOS app helps in-clinic, but no Android at launch is a gap for some practices.
SmartPrep, HCC insights, AI Coding, and Customization Studio form a genuine progression from basic ambient capture to revenue cycle intelligence — that's real depth beyond Nuance DAX's core offering.
Epic and Athenahealth integration plus Automated Ordering to EHR indicates the post-visit write-back is genuinely built in, not manual copy-paste.
Specialty practices and health systems that need ambient documentation plus coding intelligence, especially in oncology or complex chronic care.
Solo practitioners or small practices wanting self-serve signup and transparent pricing before committing to a sales process.
Kills pajama-time charting, but budget talks start at $350/month
“DeepScribe handles the ambient-to-EHR workflow with real specialty depth, especially oncology. No self-serve pricing means procurement adds friction before a single note gets written.”
That 99.5 KLAS rating isn't marketing decoration — KLAS scores are earned through actual clinician surveys, and a 98.8 performance score means the people using this daily aren't mad about it. The Context-Aware Documentation pulling forward labs, imaging, and prior meds is the kind of feature that sounds obvious but almost nobody does well. Nuance DAX is the category giant here, but DeepScribe's specialty depth — 5 million oncology visits per year is a real number — gives it a genuine lane.
SmartPrep as pre-visit intelligence is quietly the most useful thing for busy practices. Walk in already knowing the chart. That's time back in the morning, not just after hours. Customization Studio learning individual clinician style over time means month three should feel better than day three, which is how it should work.
The tradeoff is real though: $350–$500/provider/month for small practices, no trial, no self-serve. You're buying blind until a sales call happens. Mobile is iOS only per the evidence, Android users get nothing. For a tool that follows clinicians room to room, that's a gap worth asking about.
KLAS 98.8 performance score and specialty-tuned templates suggest real attention to clinical workflow feel, not just feature shipping.
Customization Studio learns individual style over time and dedicated AI coaching at enterprise tier suggests the product gets easier, not harder, with use.
iOS app exists but Android support isn't listed — half the clinician workforce carries Android devices.
No free trial, no self-serve, onboarding fees of $1,000–$5,000 estimated — first experience is a sales call, not a product.
SOC 2 Type II certified, AES-256 encryption, and a top KLAS security rating point to infrastructure teams that take uptime seriously.
Multi-specialty practices or health systems dealing with serious after-hours charting burden who can justify $350–$500/provider/month.
You need to try before you buy, run Android, or are a solo provider without budget for enterprise onboarding costs.
KLAS 98.8, oncology depth, zero public pricing — classic enterprise healthcare play
“DeepScribe has real specialty differentiation, especially oncology at 5 million visits annually. But no pricing page, no changelog, and contact-only sales puts friction on every evaluation.”
Three tells upfront. One: KLAS 98.8 score is a real signal — that's not a vanity award, clinicians and IT buyers track KLAS. Two: the oncology-specific AI with 5 million annual visits suggests genuine depth, not a generic wrapper on Whisper. Three: SmartPrep and HCC Code Insights push beyond transcription into workflow intelligence — that's harder to copy.
The concern isn't the product. It's the information blackout. No changelog. No API. No public pricing — third-party estimates run $350–$500/provider/month for small practices. That's $4,200–$6,000 annually per seat before onboarding fees. Nuance DAX charges similarly but Microsoft's distribution is a real moat DeepScribe doesn't have.
Exit portability is the honest weak spot. Notes live in your EHR, so data isn't hostage — but deep write-back integrations, custom templates, and trained clinician style profiles don't transfer cleanly. Switching cost is real.
Oncology-specific AI and HCC Code Insights are concrete differentiators vs. Nuance DAX and Suki, which lack comparable specialty depth publicly.
Notes push to your EHR, which helps, but Customization Studio style profiles and deep write-back integrations create real switching friction.
No public funding data, no changelog visible — KLAS momentum is a positive signal but the operational transparency is thin.
KLAS score and oncology visit count are verifiable claims; 'simplifying care' headline is soft but not egregious.
Specialty-depth focus and KLAS recognition match patterns from durable healthcare SaaS winners, not the pivot-and-die cohort.
Multi-specialty groups or oncology practices wanting specialty-tuned ambient documentation with serious EHR integration.
You need transparent pricing, API access, or a vendor with clear public funding and shipping history before signing.
Common questions answered by our AI research team
DeepScribe integrates with the most widely used EHR systems, though specific EHR names are not listed on the page. The platform is designed to fit into existing clinical workflows.
Yes, DeepScribe is purpose-built for oncology with oncology-specific AI, capturing 5 million oncology visits per year. It offers comprehensive pre-charting, context-aware notes, and automated interval history for longitudinal cancer care.
Yes, DeepScribe's AI Coding feature automates complete and compliant coding with real-time insights and audit-ready documentation, reducing administrative burden and ensuring proper reimbursement.
DeepScribe achieves top scores in the KLAS Spotlight Report, with an overall performance score of 98.8 out of 100, and is described as Secure & Compliant for clinical use.
SmartPrep prepares clinicians before visits by connecting them to the full context of care, helping them walk in informed and focused on what matters most.
DeepScribe is a San Francisco-based healthcare AI company providing an ambient clinical documentation tool for physicians.
